IC have been demonstrated in the sera of patients with JRA utilizing various assays (I). The frequency with which these IC can be detected depends on the assay, type of disease onset, and activity of disease (2) (3) (4) . IC have been detected in as high as 79% of JRA patients by at least one assay method, the highest percentage being found by either the Clq binding assay or Clq solidphase assay (2) (3) (4) . The presence of IC has been detected in all JRA onset types, but the highest percentage are found in the polyarticular-onset, 19S IgM RF positive and systemic onset (2) (3) (4) . The presence of elevated IC as detected by the C1q binding assay or the Clq solid-phase assay, also, correlated with the presence of 19S IgM RF (2, 3) and hidden 19S IgM RF (3) [i.e. 19S IgM RF which can be detected in the IgM-containing fraction by the hemolytic assay after separation of serum by acidgel filtration (5, 6) ]. IC presence has also correlated with active disease, demonstrating a connection with a more advanced stage of disease and possible prognostic parameter (3, 4) .
Because of these original observations (2, 3), we attempted to develop several IC separation procedures to further evaluate the IC to determine if possible antigenic constituents could be described (7) (8) (9) . In preliminary studies, we have shown that IC from the sera of patients with polyarticular onset and pauciarticular onset JRA could be separated and characterized by the use of the aHIgM affinity column and PEG precipitation-acid treatment. In ten JRA patients' sera, IC that contained both IgM RF and IgG were found by these methods (7) . We have also demonstrated that IC can be separated from serum and synovial fluid of patients with JRA using PEG to precipitate IC and subsequently Staphylococcal protein A to separate the IC (8) . Ten of 16 JRA patients' sera and three of five JRA patients' synovial fluids showed significant 19S IgM RF titers and IgG levels in their acid eluates separated by the PEG-Staphylococcal protein A method (8) . Sucrose density gradient analysis of these sera demonstrated elevated levels ofIC detected by the Clq solidphase assay in the fractions 2:: 19S, comparable to the previously isolated 19S IgM RF-IgG complexes (8) . In a recent study, we
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ABSTRACf. 19S IgM rheumatoid factors (RF) and hidden 19S IgM RF have been associated with increased disease activity in juvenile rheumatoid arthritis (JRA). Recently, immune complexes (Ie) were isolated from JRA sera by several methods which demonstrated the presence of 19S IgM RF. The present study evaluates 25 JRA patients' sera by separation on a Sepharose 4B column to which were bound F(ab')2 fragments of goat IgG antihuman IgM antibody to separate IgM-containing Ie. The columns were sequentially eluted with 1 M ammonia and 0.1 M glycine-HCI buffer, pH 3.0. The isolated fractions were assayed for 19S IgM RF and 7S IgM RF by ELISA, IgG levels by immunodiffusion, and by preparative isoelectric focusing. The ammonia eluate from the aHIgM column revealed IgG, 19S IgM RF in six patients, and IgM RF in four patients. All were polyarticular-onset JRA patients. In the glycine-HCl eluate of sera, 19S IgM RF and IgG were also detected in 15 patients, all six seropositive, polyarticular-onset, six seronegative, polyarticular-onset, and three pauciarticular-onset patients. Significant 7S IgG RF titers were demonstrated in the glycine-HCI eluates of six patients, five seropositive, polyarticular-onset patients, and one seronegative, polyarticular-onset patient. Analysis by preparative isoelectric focusing of the IgM RF and IgG RF positive ammonia and glycine-HCl eluates showed IgM RF throughout the pH range (4-10), but the highest amount of IgM RF was in the pH range 4.0-5.5. Significant IgG RF titers were detected only in this restricted spectrotypic area of pH 4.0-5. (7) (8) (9) . Previous studies had demonstrated the association of active disease in JRA patients with polyarticular and pauciarticular onset who had 19S IgM RF or hidden 19S IgM RF circulating in their sera (5, 6) . The new findings of the 19S IgM RF association with IC formation in JRA initiated the present study. We were interested in isolating IC from a large number of JRA patients by the aHlgM affinity column method to determine the constituents of the IC and to further characterize them by IEF. The possible short-term goals were to establish a method that would determine pathogenic IC in JRA which would relate to disease activity and prognosis. The long-term goals were to develop a method which would lead to the ability to determine the constituents of the IC and possible underlying antigen in JRA.
METHODS
Patient population. Blood was drawn from 25 children who were outpatients at the St. Louis University Children's Arthritis Clinic at Cardinal Glennon Children's Hospital, St. Louis University Doctors' Office Building, or private patients of Division rheumatologists. All patients were informed of the nature of the studies which have been previously approved by the St. Louis University Institutional Review Board and their parents were asked for written consent. Only patients meeting the criteria for diagnosis of JRA established by the Committee on JRA of The American Rheumatism Association were included (10) .
Specimen collection. Blood was drawn into clot tubes and allowed to clot for 3 h at 37" C. It was then centrifuged at 2000 rpm for 5 min at room temperature. The serum was aspirated and stored at -70°C until evaluated. ' Isolation of immune complexes by antihuman IgM affinity column. The method was performed with modifications as described by Jones et al. (11) . The IgG fraction of rabbit aHIgM serum (Behring Diagnostics, Somerville, NJ) was separated by DEAE-cellulose chromatography, concentrated, and digested with pepsin. The resulting F(ab'h fragments were isolated by gel filtration on Sephadex G-200 in 0.15 M PBS, pH 7.4 (PBS) at room temperature. The F(ab'h fragments were coupled to cyanogen bromide activated Sepharose 4B (Sigma Chemical Co., St. Louis, MO) according to Pharmacia directions. One ml ofF(ab'h coupled gel was packed into a 3-ml syringe. One ml of patient's serum was applied to the column and incubated for I h at room temperature. The column was eluted with BBS, pH 8.0. The void volume was discarded and three I ml fractions were collected while eluting with BBS. The column was then washed with BBS and 1 M NH 3 was applied. Three I-ml fractions were collected and immediately neutralized with 1 M propionic acid. Finally, 0.1 M glycine-HCI, pH 3.0 was applied and three I-ml fractions were collected and neutralized with 0.1 N NaOH. Individual fractions were stored at -70°C. A column was prepared as above with F(ab'h fragments of goat IgG with no immunologic specificity bound to Sepharose 4B for control.
ELISAfor 19S IgM RF. The assay was performed with modification of the methods described by Faith et al. (12) . Two hundred 1L1 of 5 1Lg/ml human IgG in 0.1 M NaHC0 3 were added to the wells of microtiter plates (Dynatech Labs, Inc., Alexandria, VA) and incubated overnight at 4°C. The microtiter wells were washed three times with PBS-Tween and samples, serially diluted from I: 10 to I: 1280, added. After overnight incubation, the wells were washed three times with PBS-Tween. Two hundred 1LI of an alkaline phosphatase-conjugated goat aHIgM solution (Sigma Chemical Co.), diluted I: 1000 in PBS-Tween were added and left at room temperature for 2 h. The wells were subsequently washed three times with PBS-Tween and once with double distilled water. Finally, 200 JLI of substrate solution (I mg of Sigma 104 phosphatase substrate in PBS-Tween along with 1 M diethanolamine buffer, pH 9.7 with 0.5 roM magnesium) cWoride was added to each well. The reaction was stopped after 10 min at room temperature by addition of 100 JLl of 3 M NaOH. Absorbance was read on a micro-ELISA mini reader [Dynatech (model MR-590)] to determine the titer of the IgM RF [titers > I: 16 are considered significant compared to healthy controls ELISA for 7S IgG RF. The assay was performed with modifications of the method of Faith et al. (12) . Two hundred JLl of 10 JLg/ml rabbit IgG in 0.1 M NaHC02 were added to microtiter plate wells and incubated overnight at 4°C. The microtiter plates were washed three times with PBS-Tween and allowed to dry. Twenty JLI of patient's serum sample were diluted I:50 in pepsinacetate buffer (10 JLg pepsin/ml 0.1 M acetate buffer, pH 4.4), incubated overnight at 37" C, and neutralized with equal volumes of PBS-Tween containing 80 mg disodium hydrogen phosphate/ ml. Two hundred JLI of pepsin digested sera were added to each well and incubated overnight at room temperature. Plates were washed three times with PBS-Tween. Two hundred III of glucose oxidase conjugated F(ab'h fragments of goat aHIgG diluted I: 1000 in PBS-Tween were added to each well and incubated for 2 h at 37°C. Plates were again washed three times with PBSTween followed by the addition of 200 JLI of substrate solution to each well and incubation for I h at room temperature. Finally, the reaction was stopped by the addition of 100 JLI of 3 M NaOH and read as above for the IgM RF-ELISA assay [titers> 1:16 are considered significant compared to healthy controls (8)].
Hemolytic assay for the presence of 19S IgM RF. The assay was performed on the IgM-containing fractions from a Sephadex G-200 column as previously described in detail (5, 6) .
IgG level measurement in immune complexes. Low level radial immunodiffusion plates (Behring-Calbiochem, La Jolla, CA) were used to measure IgG levels on aHlgM affinity column fractions.
IEF. The method of Manrique and Lansky (13) was used with minor modifications. A 2-ml sample was desalted by dialysis or by passing the sample over a Sephadex G-25 column in the proper ampholyte. A mixed agarose-Sephadex IEF [2.5 g Sephadex IEF (Ultradex), 0.5 gm Agarose IEF, 8.0 g Sorbitol, and 91.3 ml double distilled water] gel was prepared. The gel was attached to a power supply and run for 8-10 h at 4°C at a constant power of IS W. The run was stopped when properly focused and a print was made. The paper was fixed with tricWoroacetic acid (10-20%) for 10-15 min and stained with 0.2% Coomassie blue in a 50:50: 10 methanol/H20/acetic acid mixture for 15 min. The gel was fractionated by pressing a 30-s10t grid firmly into the gel. Each fraction was composed of two gel strips in 2-4 ml H20 for a total of 15 fractions. The fractions were crushed thoroughly. The pH of each fraction was determined and the mixture frozen at -20°C. The fractions were thawed and centrifuged at 3000 rpm for 10 min to precipitate insoluble gel. The supernatants containing the protein fractions were analyzed as described above.
RESULTS
Sera was collected from 25 children with JRA, six polyarticular onset, seropositive for 19S IgM RF, 12 polyarticular onset, seronegative, and seven pauciarticular onset (Table I ). The sera were subjected to affinity chromatography on an aHIgM affinity column. The resultant fractions were tested for 19S IgM RF and (Table 2 ). This was also seen in the BBS fractions of four patients when tested for IgG RF (Jh, Nz, Tb, Td) ( Table 2) . Sera from five healthy children used as controls had no IgM RF or IgG RF by ELISA or IgG in the NH 3 or glycine-HCl eluates. The NH and glycine-HCl eluates, positive for IgM RF and IgG RF, were subsequently analyzed by preparative IEF. On evaluation of the IEF fractions, 19S IgM RF were detected throughout the pH range, but predominantly acidic proteins with isoelectric points of 4.0-5.5. A typical IEF pattern is shown in Figure 1 and the 19S IgM RF and 7S IgG RF titers of the resulting fractions in Table 3 . The IgG RF demonstrated a restricted spectrotype pattern being found mainly in the pH range of 4.0-5.5 (Table   3 ).
DISCUSSION
IC have been detected by several methods in the sera ofpatients with JRA (1-4) . IC presence correlated with the presence of 19S IgM RF (2,3), hidden 19S IgM RF (3), and active disease (3, 4) in early studies. Further separation and characterization of IC in the sera of patients with JRA utilizing various procedures also demonstrated the presence of 19S IgM RF, 7S IgG, and 7S IgG RF in these IC (7) (8) (9) . The same IC were demonstrated to be complement-fixing by use of immunosorbent columns to which were bound antihuman Clq and antihuman C3 (9). These previous studies have supported the participation of classic 19S IgM RF, 7S IgG RF, IgG, and hidden 19S IgM RF in IC formation in JRA patients.
The present study demonstrates IC-like material can be detected in the sera of a large number of JRA patients after patients demonstrated both 19S IgM RF and 7S IgG RF in their IC (11) . The presence of both RF usually is seen in adult patients with more severe disease and worse prognosis (11) . This suggests a common etiology of these six polyarticular onset patients and adult patients with RA. All seven of the patients with IgG RF in their IC have severe, polyarticular disease being treated with gold salts. Nine of the other 10 who demonstrated significant 19S IgM RF titers in their isolated IC also had hidden 19S IgM RF in their sera. These patients will have to be followed to see if the presence of these IC denotes a worse prognosis. The reason why nine patients had significant 19S IgM RF titers in the BBS fraction is not clear. It is conceivable that IgM RF formation with IgG or IgG RF results in steric hindrance thus preventing firm attachment of the IgM RF to the aHIgM affinity column. Alternatively, saturation of the affinity column has to be considered also, since all aHIgM antibodies cannot be expected to have equally strong avidity for IgM.
Fifteen of the 16 patients had IgG detected in their eluates. The findings of the IgG and IgG RF in the eluates demonstrated the presence of IC The IgG most likely had to be bound to the 19S IgM RF or in combination with 19S IgM RF and 7S IgG RF, because the column was specific for binding of only human IgM. However, the possibility of naturally occurring IgG anti-F(ab')2 or anti-Fab antibodies which have been detected in patients with RA (14-16) and JRA (17) could account for the IgG in the immune complex containing eluates. They could account for a small portion of the IgG, but for five reasons not all of the IgG detected. First, the concentration of anti-Fab and anti-F(ab'h antibodies detected in RA patients is usually around 5 ttgjml (14, 15) ; whereas, our IgG levels detected in the IC in six patients were>70 ttgjml and at least 10 ttgjml in the other nine JRA patients. Second, a recent study of IEF on anti-Fab antibodies demonstrated the majority was of the isotypes IgG4 and IgG3, especially the acidic clonally restricted anti-Fab antibodies (16) . Our IC were also acidic clonally restricted in the pH range 4.0-5.5, but have been shown by specificity studies to be mainly IgGI antibodies directed toward 19S IgM RF and hidden 19S IgM RF in JRA patients (18, 19) . Third, specificity studies performed in detail showed the binding site for the IgM RF to be in the 0)'3 homology area of the IgGI molecule, not in the CI'I or hinge region as for the anti-Fab and anti-F(ab'h antibodies (18) . Fourth, they would not explain the IgG RF being present in the eluates. There would have to be complete cross reactivity between the anti-Fab and anti-F(ab'h antibodies and IgG RF, because in most patients with JRA IgG RF levels are> I0 ttgjml (20) . Fifth, the sera of four patients with high levels of IgG in their glycine-HCl eluates demonstrated no IgG in their NH 3 or glycine-HCI eluates from the affinity column which had F(ab'h fragments of goat IgG of no immunologic specificity bound.
The (22) have demonstrated clonally restricted IC in vitro by preparation of human serum albuminantihuman serum albumin IC They demonstrated human serum albumin-antihuman serum albumin IC only in the pH range of 4.5-5.0, similar to our IC in JRA. These acidic clonally restricted IC identified in our JRA patients, therefore, could playa part in pathogenesis. Using 19S IgM RF and 7S IgG RF as markers for the identification of the IC in JRA patients in serial studies may lead to the demonstration of a more aggressive disease, a poorer prognosis, and therefore to possibly be more aggressive with treatment. It also opens up a new area for future research. The ability to further define the constituents of these IC may aid in determining the underlying antigen and disease pathogenesis in JRA. Work on evaluating these IC for glycolipids of viral origin, glycosaminoglycans, and peptidoglycan-polysaccharides of bacterial origin is in progress.
